Key result
Calpain inhibitors and specific siRNAs completely blocked echovirus 1 infection in host cells by effectively inhibiting the synthesis of viral RNA.
Calpain 1 and 2 are essential for the RNA replication of echovirus 1 and other picornaviruses, suggesting a potential host-directed therapeutic target for these infections.
Calpain inhibition merits further preclinical study as a host-directed antiviral approach; leaves open therapeutic potential for human picornavirus infections.
Calpains are calcium-dependent cysteine proteases that degrade cytoskeletal and cytoplasmic proteins. We have studied the role of calpains in the life cycle of human echovirus 1 (EV1). The calpain inhibitors, including calpeptin, calpain inhibitor 1, and calpain inhibitor 2 as well as calpain 1 and calpain 2 short interfering RNAs, completely blocked EV1 infection in the host cells. The effect of the inhibitors was not specific for EV1, because they also inhibited infection by other picornaviruses, namely, human parechovirus 1 and coxsackievirus B3. The importance of the calpains in EV1 infection also was supported by the fact that EV1 increased calpain activity 3 h postinfection. Confocal microscopy and immunoelectron microscopy showed that the EV1/caveolin-1-positive vesicles also contain calpain 1 and 2. Our results indicate that calpains are not required for virus entry but that they are important at a later stage of infection. Calpain inhibitors blocked the production of EV1 particles after microinjection of EV1 RNA into the cells, and they effectively inhibited the synthesis of viral RNA in the host cells. Thus, both calpain 1 and calpain 2 are essential for the replication of EV1 RNA.
No takes yet. Share an insight, caveat, or question.
Upla et al. (2007) studied Echovirus 1 infection (in vitro). Calpain inhibitors (calpeptin, calpain inhibitor 1 and 2) and siRNAs vs. Untreated or scrambled siRNA control was evaluated on EV1 infection and RNA replication. Calpain inhibitors and specific siRNAs completely blocked echovirus 1 infection in host cells by effectively inhibiting the synthesis of viral RNA.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: